Bluebird Bio Company
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer
Investment Stage:
N/A
Headquarters:
United Kingdom
Last Funding Date:
2016-12-07
Funding Status:
IPO
Investors Number:
13
Founded Date:
01.01.1993
Investor Type:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
N/A
Employee Number:
501-1000
Total Funding:
409000000 USD
Industry:
Stem Cell Exhaustion
Estimated Revenue:
$10M to $50M
Technology:
Genetic Test & Molecular Diagnostics